Cargando…
Using naltrexone to validate a human laboratory test system to screen new medications for alcoholism (TESMA)- a randomized clinical trial
This registered clinical trial sought to validate a laboratory test system devised to screen medications for alcoholism treatment (TESMA) under different contingencies of alcohol reinforcement. Forty-six nondependent, but at least medium-risk drinkers were given the opportunity to earn intravenous i...
Autores principales: | Spreer, Maik, Grählert, Xina, Klut, Ina-Maria, Al Hamdan, Feras, Sommer, Wolfgang H., Plawecki, Martin H., O’Connor, Sean, Böttcher, Michael, Sauer, Cathrin, Smolka, Michael N., Zimmermann, Ulrich S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076427/ https://www.ncbi.nlm.nih.gov/pubmed/37019884 http://dx.doi.org/10.1038/s41398-023-02404-7 |
Ejemplares similares
-
Acute alcohol does not impair attentional inhibition as measured with Stroop interference scores but impairs Stroop performance
por: Riedel, P., et al.
Publicado: (2021) -
Integrated Care for Pregnant Women and Parents With Methamphetamine-Related Mental Disorders
por: Petzold, Johannes, et al.
Publicado: (2021) -
Erste Erfahrungen bei der Umsetzung der EU-Verordnung 536/2014 (CTR) aus Sicht der nichtkommerziellen akademischen Forschung
por: Fuhrmann, Christine, et al.
Publicado: (2022) -
Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012) -
O-Benzoylnaltrexone
por: Yang, Rui, et al.
Publicado: (2013)